Skip to main content

Measure binding affinity and kinetics in real-time with the inQuiQ

Label-free biosensing that returns KD, ka and kd from 30 µL of sample. Integrated photonics bring multiplex, high-sensitivity interaction data to your own bench.

One label-free analysis platform for all your binding questions

Engineered Antibodies

Affinity, kinetics, and epitope binning for clone ranking.
Engineered antibodies

Small molecules
& Peptides

Reliable fragment screening and small molecule binding affinity, label-free.
Small molecules and peptides

Molecular Glues
& PROTACs

Protein degraders ternary complex kinetics and molecular glue screening.
Molecular glues and PROTACs

Structural Biology

Binding validation and affinity to complement cryo-EM.
Structural biology

Complex Biological Matrices

Binding analysis in serum, plasma, and crude samples.
Complex biological matrices

Bioprocessing

Active concentration, kinetics, and batch-to-batch comparability.
Bioprocessing

Membrane proteins

GPCR ligand binding, lipid bilayer sensors, and construct comparison.
Membrane proteins

Aggregated Proteins

Characterization of aggregated proteins and protein self-association.
Aggregated proteins

Nucleic acids

Aptamer binding affinity, hybridization kinetics, and sequence specificity.
Nucleic acids

EVs and LNPs

Binding kinetics for extracellular vesicles and lipid nanoparticles.
EVs and LNPs

Label-free interaction analysis, matched to your application

Tell us what you're measuring and we'll tell you whether the inQuiQ fits.
Talk to a specialist

Label-free biosensing for every stage of biomolecular research

From early research to advanced development, get reproducible biomolecular binding data without the complexity of traditional instruments.
The data quality is excellent and highly encouraging. The analytical performance is highly impressive, particularly considering the complexity of the PD-1/PD-L1 interaction studies we do.
Prof. Dr. Norbert Sewald
Organic and Bioorganic Chemistry

PD-1/PD-L1 binding kinetics

Characterization of PD-1/PD-L1 binding, delivering reproducible kinetic measurements with a KD of 37.7 nM.

From sample to signal
Built around flexible assay setup

The inQuiQ connects flexible sample handling, photonic detection, and real-time data output in a workflow that brings a photonic approach to surface plasmon resonance-style label-free biosensing.

0 1

Sample

Start with the material your lab already has. Purified or crude, filtered through 0.22 µm.


  • Proteins, antibodies, and peptides
  • Small molecules and DNA
  • Serum, plasma, and lysate
  • EVs and LNPs
0 2

Flexible 4-Channel Setup

Four channels allow users to flexibly run different assays, conditions, references, or experiments.

1Reference
2Analyte 1
3Analyte 2
4Analyte 3
0 3

Label-free detection on a photonic chip

Binding at the surface shifts the local refractive index. The photonic chip reads that shift and turns it into a signal.

light in → ← light out
0 4

Real-time binding affinity measurement

Translate interaction behaviour into real-time kinetic and affinity insight.

inQuiQ Software - Sensorgram View
RU
Ch 1 Ch 2 Ch 3

Why labs are moving beyond surface plasmon resonance & bio-layer interferometry

Surface plasmon resonance
  • Scaling requires a new instrument
  • Bulky instrument with at least 1 to 24-hour equilibration

  • Gold chip surface challenging for complex matrix assays
  • Instrument, service, and specialist cost stacks up
inQuiQ integrated photonics
  • Modular platform with high-throughput pathway
  • 4-channel flow-cell in a benchtop instrument
  • Strong small molecule sensitivity and broad application fit
  • Low cost of ownership with photonic technology
Biolayer interferometry
  • Dip sensor sensitivity limits weak and small analytes
  • Increasing throughput requires a new instrument
  • Only parallel samples, with a single "channel"

  • Single-use tips make cost per sample climb
Start A conversation

Tell us about your binding questions

Some teams want to see the instrument run. Others need the numbers first, or a conversation about whether the assay will work at all.

Ready to see the inQuiQ in action?